98 related articles for article (PubMed ID: 11405600)
21. Anti-EBNA-1 (carboxy-half) IgG antibodies as a seroepidemiological marker for Epstein-Barr virus infection.
Nebel-Schickel H; Hinderer W; Saavedra C; Schmutzler R; Horn J; Vornhagen R; Sonneborn HH
Beitr Infusionsther Transfusionsmed; 1994; 32():134-7. PubMed ID: 9422107
[TBL] [Abstract][Full Text] [Related]
22. [Evaluation of IgG-IgM antibodies against the Epstein-Barr virus nuclear antigen (EBNA-1) using ELISA].
Martínez Zapico R; Sobejano L; Llamazares I; Ladrón de Guevara C
Enferm Infecc Microbiol Clin; 1992 May; 10(5):281-3. PubMed ID: 1327168
[TBL] [Abstract][Full Text] [Related]
23. Serological diagnosis of infectious mononucleosis using three anti-Epstein-Barr virus recombinant ELISAs.
Färber I; Wutzler P; Wohlrabe P; Wolf H; Hinderer W; Sonneborn HH
J Virol Methods; 1993 May; 42(2-3):301-7. PubMed ID: 8390476
[TBL] [Abstract][Full Text] [Related]
24. Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia.
Karray H; Ayadi W; Fki L; Hammami A; Daoud J; Drira MM; Frikha M; Jlidi R; Middeldorp JM
J Med Virol; 2005 Apr; 75(4):593-602. PubMed ID: 15714486
[TBL] [Abstract][Full Text] [Related]
25. Analysis of antibody titers to Epstein-Barr virus nuclear antigens in sera of patients with Sjögren's syndrome and with rheumatoid arthritis.
Inoue N; Harada S; Miyasaka N; Oya A; Yanagi K
J Infect Dis; 1991 Jul; 164(1):22-8. PubMed ID: 1647426
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of a new ELISA for the detection of specific IgG to the Epstein-Barr nuclear antigen 1 (EBNA-1).
Schenk BI; Michel PO; Enders G; Thilo N; Radtke M; Oker-Blom C; Franke D
Clin Lab; 2007; 53(3-4):151-5. PubMed ID: 17447651
[TBL] [Abstract][Full Text] [Related]
27. Comparative evaluation of the new ARCHITECT EBV assays considering different testing algorithms.
Sickinger E; Berth M; Vockel A; Braun HB; Oer M; Buenning C
Diagn Microbiol Infect Dis; 2014 Jul; 79(3):310-6. PubMed ID: 24809858
[TBL] [Abstract][Full Text] [Related]
28. Comparison of Abbott Architect
François C; Segard C; Bouvier M; Stefanski M; Pannier C; Zawadzki P; Roussel C; Hecquet D; Duverlie G; Brochot E; Castelain S
Diagn Microbiol Infect Dis; 2018 Feb; 90(2):96-101. PubMed ID: 29198371
[TBL] [Abstract][Full Text] [Related]
29. Use of enzyme-linked immunosorbent assays with chimeric fusion proteins to titrate antibodies against Epstein-Barr virus nuclear antigen 1.
Inoue N; Kuranari J; Harada S; Nakajima H; Ohbayashi M; Nakamura Y; Miyasaka N; Ezawa K; Ban F; Yanagi K
J Clin Microbiol; 1992 Jun; 30(6):1442-8. PubMed ID: 1320628
[TBL] [Abstract][Full Text] [Related]
30. Characterization of the serological response in man to the latent membrane protein and the six nuclear antigens encoded by Epstein-Barr virus.
Rowe M; Finke J; Szigeti R; Klein G
J Gen Virol; 1988 Jun; 69 ( Pt 6)():1217-28. PubMed ID: 2838572
[TBL] [Abstract][Full Text] [Related]
31. The serological signs of the Epstein-Barr virus (EBV) activity in the elderly.
Ternák G; Szúcs G; Uj M
Acta Microbiol Immunol Hung; 1997; 44(2):133-40. PubMed ID: 9330661
[TBL] [Abstract][Full Text] [Related]
32. Comparison of a multiplexed bead-based assay with an immunofluorescence and an enzyme-immuno assay for the assessment of Epstein-Barr virus serologic status.
Devanthéry O; Meylan P
Clin Microbiol Infect; 2010 Dec; 16(12):1776-82. PubMed ID: 20219083
[TBL] [Abstract][Full Text] [Related]
33. Potential role of the Epstein-Barr virus in systemic lupus erythematosus autoimmunity.
Incaprera M; Rindi L; Bazzichi A; Garzelli C
Clin Exp Rheumatol; 1998; 16(3):289-94. PubMed ID: 9631751
[TBL] [Abstract][Full Text] [Related]
34. High incidence of elevated antibody titers to Epstein-Barr virus in patients with uveitis.
Touge C; Agawa H; Sairenji T; Inoue Y
Arch Virol; 2006 May; 151(5):895-903. PubMed ID: 16362642
[TBL] [Abstract][Full Text] [Related]
35. Multiple sclerosis and Epstein-Barr virus.
Levin LI; Munger KL; Rubertone MV; Peck CA; Lennette ET; Spiegelman D; Ascherio A
JAMA; 2003 Mar; 289(12):1533-6. PubMed ID: 12672770
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheumatoid arthritis.
Blaschke S; Schwarz G; Moneke D; Binder L; Müller G; Reuss-Borst M
J Rheumatol; 2000 Apr; 27(4):866-73. PubMed ID: 10782808
[TBL] [Abstract][Full Text] [Related]
37. Seroepidemiology of EBV and interpretation of the "isolated VCA IgG" pattern.
De Paschale M; Agrappi C; Manco MT; Mirri P; Viganò EF; Clerici P
J Med Virol; 2009 Feb; 81(2):325-31. PubMed ID: 19107979
[TBL] [Abstract][Full Text] [Related]
38. Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis.
Levin LI; Munger KL; Rubertone MV; Peck CA; Lennette ET; Spiegelman D; Ascherio A
JAMA; 2005 May; 293(20):2496-500. PubMed ID: 15914750
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of a multiplexed bead assay for assessment of Epstein-Barr virus immunologic status.
Klutts JS; Liao RS; Dunne WM; Gronowski AM
J Clin Microbiol; 2004 Nov; 42(11):4996-5000. PubMed ID: 15528686
[TBL] [Abstract][Full Text] [Related]
40. Application of virus-specific immunoglobulin M (IgM), IgG, and IgA antibody detection with a polyantigenic enzyme-linked immunosorbent assay for diagnosis of Epstein-Barr virus infections in childhood.
Schaade L; Kleines M; Häusler M
J Clin Microbiol; 2001 Nov; 39(11):3902-5. PubMed ID: 11682505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]